Skip to main content

STIFEL FINANCIAL CORP

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 720672 ST. LOUIS, MO

Position in TAK

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$11,640,744
+$2,999,365 QoQ
Shares Held
628,550
+13.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98.25534961419139.ToString("F0")% Shared 0.ToString("F0")% None 1.7446503858086069.ToString("F0")%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $156,487,204 across 25 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (7.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 TAK
Takeda Pharmaceutical Co Ltd
This page
628,550 $11,640,744

All Filings in TAK

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,640,744 628,550
2025-12-31 $8,641,379 554,290
2025-09-30 $7,450,645 508,924
2025-06-30 $7,019,132 454,019
2025-03-31 $5,974,497 401,782
2024-12-31 $5,761,266 435,141
2024-09-30 $6,266,269 440,666
2024-06-30 $2,795,970 216,072
2024-03-31 $4,086,645 294,215
2023-12-31 $2,974,480 208,443
2023-09-30 $4,545,286 293,813
2023-06-30 $4,383,827 279,047
2023-03-31 $4,535,096 275,188
2022-12-31 $1,766,994 113,269
2022-09-30 $1,604,349 123,697
2022-06-30 $1,523,550 108,515
2022-03-31 $1,372,370 95,836
2021-12-31 $1,185,154 86,952
2021-09-30 $1,257,000 76,740
2021-06-30 $1,086,577 64,562
2021-03-31 $1,171,907 64,179
2020-12-31 $2,862,931 157,304
2020-09-30 $3,576,722 200,489
2020-06-30 $3,668,584 204,606
2020-03-31 $3,319,334 218,665